It's hitting the fan on November 8th

"because Bydureon is a dog"

So, if Bydureon is a dog than WTF is Tradjenta?

So, if Bydureon is a dog than WTF is Tradjenta?

Tradjenta is probably a pile of garbage a la Effient and Erbitux, but it may be too soon to tell for sure. For certain, with the inept Lilly marketing it in the US market, it has a tough road ahead. This whole class of drugs apparently has mediocre (at best) efficacy, but T2D is such a huge market that there is potential.